29 May 2018 07:00
News Release
London, 27 May 2018
Â
Â
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
Â
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
Â
Sunday 27 May 2018
Â
Smiths Group plc ("Smiths")
Â
Statement regarding Smiths Medical
Â
Smiths notes the press speculation regarding discussions involving its Smiths Medical business and confirms that it is in very early stage discussions about a potential combination of its medical division with ICU Medical, Inc. (NASDAQ: ICUI).
Â
The Board of Smiths routinely reviews all options for the Group's portfolio of businesses to maximise value for Smiths shareholders.
Â
There can be no certainty that a transaction will be concluded.
Â
END
Â
Â
Contact details  | |
Investor enquiries | |
Jemma Spalton, Smiths Group +44 (0)20 7004 1637 +44 (0)78 6739 0350 jemma.spalton@smiths.com  | Marion Le Bot, Smiths Group+44 (0)20 7004 1672+44 (0)75 8315 4386marion.lebot@smiths.com  |
Media enquiries | |
Deborah Scott, FTI Consulting+44 (0)20 3727 1459+44 (0)797 953 7449smiths@fticonsulting.com  | Alex Le May, FTI Consulting+44 (0)20 3727 1308+44 (0)7702 443 312smiths@fticonsulting.com  |
Â
Â
About Smiths Group
Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the medical technology, security & defence, general industrial, oil & gas, and space & aerospace markets worldwide. Smiths Group employs c.22,000 colleagues in over 50 countries. For more information visit www.smiths.com.
Â
About Smiths Medical
Smiths Medical is a leading supplier of specialised medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information visit www.smiths-medical.com.
Â